Company intelligence / Profile preview

Superior Biologics

Sharon Hill, Pennsylvania, United Statessuperiorbiologics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Superior Biologics is a national leader in providing commercial-stage specialty pharmacy and home infusion services for chronic and complex conditions. The company delivers intravenous immunoglobulin, clotting factors for hemophilia, and a wide range of biologic therapies across multiple specialties. It has established high levels of customer satisfaction through its accredited pharmacies and innovative care management platforms. No clinical trial results are reported as the company does not develop new drugs but distributes FDA-approved products.

Therapeutic areas: OncologyImmunologyNeurologyHematology
Modalities: BiologicProtein
Industry: Non-Academic Healthcare

Partnerships

Coherus BioSciences (national distribution agreement for YUSIMRY™)

Beyond the preview

Go deeper on Superior Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superior Biologics.

Explore the full profile